SLDB – solid biosciences inc. (US:NASDAQ)
Stock Stats
News
Solid Biosciences: Positive FDA Meeting For SGT-003 Sets Up Next Milestones [Seeking Alpha]
Solid Biosciences (NASDAQ:SLDB) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $16.00 price target on the stock.
Solid Biosciences Announces Positive Feedback from Type C Meeting with FDA for SGT-003 Gene Therapy for Duchenne Muscular Dystrophy
Solid Biosciences to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 [Yahoo! Finance]
Solid Biosciences to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
Form 4 Solid Biosciences Inc. For: Feb 04 Filed by: Howton David T
Form 4 Solid Biosciences Inc. For: Feb 04 Filed by: Cumbo Alexander
Form 4 Solid Biosciences Inc. For: Feb 04 Filed by: Ganot Ilan
Form 4 Solid Biosciences Inc. For: Feb 04 Filed by: Tan Kevin
Form 4 Solid Biosciences Inc. For: Feb 04 Filed by: Brooks Gabriel
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.